KEY FEATURES
| Full Name | Macrophage Colony Stimulating Factor 1 |
|---|---|
| Synonym | M-CSF;CSF1;CSF-1; |
| Assay Type | Sandwich |
| Reactivity | Human |
| Range | 31.25-2000pg/mL |
| Sensitivity | 18.75pg/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Human MCSF in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human MCSF. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human MCSF and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human MCSF, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human MCSF. You can calculate the concentration of Human MCSF in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human MCSF ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (pg/mL) | 106.64 | 268.08 | 684.23 | 100.28 | 242.95 | 640.08 |
| Standard deviation | 5.89 | 15.71 | 25.04 | 6.45 | 11.18 | 24.52 |
| CV(%) | 5.52 | 5.86 | 3.66 | 6.43 | 4.6 | 3.83 |
RECOVERY
The recovery of Human MCSF spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 91-106 | 97 |
| EDTA plasma (n=8) | 95-110 | 102 |
| Cell culture media (n=8) | 93-104 | 98 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human MCSF in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with IL3 ELISA Kits
| IL2 ELISA Kit | publications with IL3 and IL2 |
| IL5 ELISA Kit | publications with IL3 and IL5 |
| JAK2 ELISA Kit | publications with IL3 and JAK2 |
| IL7 ELISA Kit | publications with IL3 and IL7 |
| CSF2RB ELISA Kit | publications with IL3 and CSF2RB |
| IL3RA ELISA Kit | publications with IL3 and IL3RA |
| FOS ELISA Kit | publications with IL3 and FOS |
| GRB2 ELISA Kit | publications with IL3 and GRB2 |
| PIK3CA ELISA Kit | publications with IL3 and PIK3CA |
Pathways associated with IL3 ELISA Kit
| Apoptosis Pathway | Apoptosis Pathway |
| Asthma Pathway | Asthma Pathway |
| Calcineurin-regulated NFAT-dependent Transcription In Lymphocytes Pathway | Calcineurin-regulated NFAT-dependent Transcription In Lymphocytes Pathway |
| Calcium Signaling In The CD4+ TCR Pathway | Calcium Signaling In The CD4+ TCR Pathway |
| Cytokine Signaling In Immune System Pathway | Cytokine Signaling In Immune System Pathway |
| Cytokine-cytokine Receptor Interaction Pathway | Cytokine-cytokine Receptor Interaction Pathway |
| Fc Epsilon RI Signaling Pathway | Fc Epsilon RI Signaling Pathway |
Diseases associated with IL3 ELISA Kit
| Bone Marrow Diseases | publications with IL3 and Bone Marrow Diseases |
| Necrosis | publications with IL3 and Necrosis |
| Disease Models, Animal | publications with IL3 and Disease Models, Animal |
| Lung Diseases | publications with IL3 and Lung Diseases |
| Inflammation | publications with IL3 and Inflammation |
| Asthma | publications with IL3 and Asthma |
| Anemia | publications with IL3 and Anemia |
| Nervous System Diseases | publications with IL3 and Nervous System Diseases |
| Brain Diseases | publications with IL3 and Brain Diseases |
| Kidney Diseases | publications with IL3 and Kidney Diseases |
Organs/Tissues associated with IL3 ELISA Kit
| Mixed | publications with IL3 and Mixed |